Literature DB >> 27500494

Oxygen metabolism and barrier regulation in the intestinal mucosa.

Louise E Glover, J Scott Lee, Sean P Colgan.   

Abstract

Mucosal surfaces are lined by epithelial cells and provide an important barrier to the flux of antigens from the outside. This barrier is provided at a number of levels, including epithelial junctional complexes, mucus production, and mucosa-derived antimicrobials. Tissue metabolism is central to the maintenance of homeostasis in the mucosa. In the intestine, for example, baseline pO2 levels are uniquely low due to counter-current blood flow and the presence of large numbers of bacteria. As such, hypoxia and HIF signaling predominates normal intestinal metabolism and barrier regulation during both homeostasis and active inflammation. Contributing factors that elicit important adaptive responses within the mucosa include the transcriptional regulation of tight junction proteins, metabolic regulation of barrier components, and changes in autophagic flux. Here, we review recent literature around the topic of hypoxia and barrier function in health and during disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27500494      PMCID: PMC5096807          DOI: 10.1172/JCI84429

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  138 in total

1.  Control of creatine metabolism by HIF is an endogenous mechanism of barrier regulation in colitis.

Authors:  Louise E Glover; Brittelle E Bowers; Bejan Saeedi; Stefan F Ehrentraut; Eric L Campbell; Amanda J Bayless; Evgenia Dobrinskikh; Agnieszka A Kendrick; Caleb J Kelly; Adrianne Burgess; Lauren Miller; Douglas J Kominsky; Paul Jedlicka; Sean P Colgan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

2.  Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice.

Authors:  Myung H Kim; Seung G Kang; Jeong H Park; Masashi Yanagisawa; Chang H Kim
Journal:  Gastroenterology       Date:  2013-05-07       Impact factor: 22.682

3.  A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection.

Authors:  Cheryl Y M Okumura; Andrew Hollands; Dan N Tran; Joshua Olson; Samira Dahesh; Maren von Köckritz-Blickwede; Wdee Thienphrapa; Courtney Corle; Seung Nam Jeung; Anna Kotsakis; Robert A Shalwitz; Randall S Johnson; Victor Nizet
Journal:  J Mol Med (Berl)       Date:  2012-02-28       Impact factor: 4.599

4.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

5.  Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex.

Authors:  Jean-Marc Blouin; Graziella Penot; Martine Collinet; Magali Nacfer; Claude Forest; Pierre Laurent-Puig; Xavier Coumoul; Robert Barouki; Chantal Benelli; Sylvie Bortoli
Journal:  Int J Cancer       Date:  2010-10-08       Impact factor: 7.396

6.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.

Authors:  Kendle M Maslowski; Angelica T Vieira; Aylwin Ng; Jan Kranich; Frederic Sierro; Di Yu; Heidi C Schilter; Michael S Rolph; Fabienne Mackay; David Artis; Ramnik J Xavier; Mauro M Teixeira; Charles R Mackay
Journal:  Nature       Date:  2009-10-29       Impact factor: 49.962

7.  Central role of Muc5ac expression in mucous metaplasia and its regulation by conserved 5' elements.

Authors:  Hays W J Young; Olatunji W Williams; Divay Chandra; Lindsey K Bellinghausen; Guillermina Pérez; Alberto Suárez; Michael J Tuvim; Michelle G Roy; Samantha N Alexander; Seyed J Moghaddam; Roberto Adachi; Michael R Blackburn; Burton F Dickey; Christopher M Evans
Journal:  Am J Respir Cell Mol Biol       Date:  2007-04-26       Impact factor: 6.914

8.  Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study.

Authors:  S P Jørgensen; J Agnholt; H Glerup; S Lyhne; G E Villadsen; C L Hvas; L E Bartels; J Kelsen; L A Christensen; J F Dahlerup
Journal:  Aliment Pharmacol Ther       Date:  2010-05-11       Impact factor: 8.171

9.  Paneth cells as a site of origin for intestinal inflammation.

Authors:  Timon E Adolph; Michal F Tomczak; Lukas Niederreiter; Hyun-Jeong Ko; Janne Böck; Eduardo Martinez-Naves; Jonathan N Glickman; Markus Tschurtschenthaler; John Hartwig; Shuhei Hosomi; Magdalena B Flak; Jennifer L Cusick; Kenji Kohno; Takao Iwawaki; Susanne Billmann-Born; Tim Raine; Richa Bharti; Ralph Lucius; Mi-Na Kweon; Stefan J Marciniak; Augustine Choi; Susan J Hagen; Stefan Schreiber; Philip Rosenstiel; Arthur Kaser; Richard S Blumberg
Journal:  Nature       Date:  2013-10-02       Impact factor: 49.962

10.  Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis.

Authors:  S Keely; E L Campbell; A W Baird; P M Hansbro; R A Shalwitz; A Kotsakis; E N McNamee; H K Eltzschig; D J Kominsky; S P Colgan
Journal:  Mucosal Immunol       Date:  2013-05-22       Impact factor: 7.313

View more
  42 in total

Review 1.  The dichotomous nature of T helper 17 cells.

Authors:  Brigitta Stockinger; Sara Omenetti
Journal:  Nat Rev Immunol       Date:  2017-05-30       Impact factor: 53.106

Review 2.  Tissue metabolism and the inflammatory bowel diseases.

Authors:  Jordi M Lanis; Daniel J Kao; Erica E Alexeev; Sean P Colgan
Journal:  J Mol Med (Berl)       Date:  2017-05-20       Impact factor: 4.599

3.  Anemia induces gut inflammation and injury in an animal model of preterm infants.

Authors:  Connie M Arthur; Demet Nalbant; Henry A Feldman; Bejan J Saeedi; Jason Matthews; Brian S Robinson; Nourine A Kamili; Ashley Bennett; Gretchen A Cress; Martha Sola-Visner; Rheinallt M Jones; M Bridget Zimmerman; Andrew S Neish; Ravi M Patel; Peggy Nopoulos; Michael K Georgieff; John D Roback; John A Widness; Cassandra D Josephson; Sean R Stowell
Journal:  Transfusion       Date:  2019-03-21       Impact factor: 3.157

4.  William Kaelin, Peter Ratcliffe, and Gregg Semenza receive the 2016 Albert Lasker Basic Medical Research Award.

Authors:  Jillian H Hurst
Journal:  J Clin Invest       Date:  2016-09-13       Impact factor: 14.808

5.  Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis.

Authors:  Cen Xie; Tomoki Yagai; Yuhong Luo; Xianyi Liang; Tao Chen; Qiong Wang; Dongxue Sun; Jie Zhao; Sadeesh K Ramakrishnan; Lulu Sun; Chunmei Jiang; Xiang Xue; Yuan Tian; Kristopher W Krausz; Andrew D Patterson; Yatrik M Shah; Yue Wu; Changtao Jiang; Frank J Gonzalez
Journal:  Nat Med       Date:  2017-10-09       Impact factor: 53.440

Review 6.  Gut microbiota and IBD: causation or correlation?

Authors:  Josephine Ni; Gary D Wu; Lindsey Albenberg; Vesselin T Tomov
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-07-19       Impact factor: 46.802

7.  Hypoxanthine is a checkpoint stress metabolite in colonic epithelial energy modulation and barrier function.

Authors:  J Scott Lee; Ruth X Wang; Erica E Alexeev; Jordi M Lanis; Kayla D Battista; Louise E Glover; Sean P Colgan
Journal:  J Biol Chem       Date:  2018-02-27       Impact factor: 5.157

Review 8.  Visceral Congestion in Heart Failure: Right Ventricular Dysfunction, Splanchnic Hemodynamics, and the Intestinal Microenvironment.

Authors:  Vincenzo B Polsinelli; Arjun Sinha; Sanjiv J Shah
Journal:  Curr Heart Fail Rep       Date:  2017-12

Review 9.  Regulation of immunity and inflammation by hypoxia in immunological niches.

Authors:  Cormac T Taylor; Sean P Colgan
Journal:  Nat Rev Immunol       Date:  2017-10-03       Impact factor: 53.106

10.  Ubc9 overexpression and SUMO1 deficiency blunt inflammation after intestinal ischemia/reperfusion.

Authors:  Jörn Karhausen; Joshua D Bernstock; Kory R Johnson; Huaxin Sheng; Qing Ma; Yuntian Shen; Wei Yang; John M Hallenbeck; Wulf Paschen
Journal:  Lab Invest       Date:  2018-02-22       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.